BIOSeedin Winter Innovation Partnering Summit @JPM Week

📍 San Francisco, CA
📅 January 11 , 2026

Redefining Licensing in the New Era
Join global leaders from pharma and biotech to shape the future of strategic partnerships.

Why Attend?
✅ In-depth China–US licensing discussions
✅ Live asset pitches from innovative biotech companies
✅ Exclusive networking with top decision-makers

Event Highlights

• Spotlight on China Asset Roadshows
  Over ten innovative Chinese biopharma companies in oncology, autoimmune, and metabolic diseases will showcase their latest R&D progress and partnering needs.

• Engagement with MNCs and Global Investors
  Executives from multinational pharma companies (MNCs) and leading international investment firms will join panel discussions and on-site exchanges, fostering cross-border collaboration.

• Efficient 1-on-1 Partnering System
  Dedicated meeting tables will be available for face-to-face discussions between participating companies, investors, and potential partners. A pre-scheduled partnering system ensures efficiency and productivity.

• Focused Panel Discussions on Three Hot Areas
  The forum will host three focused panel discussions covering oncology, metabolic diseases, and autoimmune diseases, exploring R&D trends, partnership opportunities, and in-depth insights within each field.

1-on-1 Partnering Sessions

• 9:00 AM –17:30 PM (11 meeting tables, 30-minute slots)

Expected Participants

This event is expected to attract:

• BD & Licensing executives from multinational pharma companies (MNCs)
• Senior executives from overseas biotech companies
• Investors from leading international investment firms
• Founders and management of innovative Chinese biopharma companies
• Professionals from legal, consulting, and service organizations